Global Alzheimer's Disease Diagnostic Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Genetic testing
  • 1.4.3 Neurological exam
  • 1.4.4 Mini-mental state exam (MMSE)
  • 1.4.5 Brain imaging
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Alzheimer's Disease Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Clinics
  • 1.5.3 Hospitals
  • 1.5.4 Diagnostic Centers
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2015-2026)
• 2.2 Global Alzheimer's Disease Diagnostic Growth Trends by Regions
  • 2.2.1 Alzheimer's Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Alzheimer's Disease Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Alzheimer's Disease Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Alzheimer's Disease Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Alzheimer's Disease Diagnostic Players by Market Size
  • 3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
  • 3.2.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2019
• 3.3 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
• 3.5 Date of Enter into Alzheimer's Disease Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 6.2 Alzheimer's Disease Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 7.2 Alzheimer's Disease Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 8.2 Alzheimer's Disease Diagnostic Key Players in China (2019-2020)
• 8.3 China Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 8.4 China Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 9.2 Alzheimer's Disease Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 10.2 Alzheimer's Disease Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 11.2 Alzheimer's Disease Diagnostic Key Players in India (2019-2020)
• 11.3 India Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 11.4 India Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Alzheimer's Disease Diagnostic Market Size (2015-2020)
• 12.2 Alzheimer's Disease Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Eli Lilly
  • 13.1.1 Eli Lilly Company Details
  • 13.1.2 Eli Lilly Business Overview
  • 13.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
  • 13.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2015-2020))
  • 13.1.5 Eli Lilly Recent Development
• 13.2 TauRx
  • 13.2.1 TauRx Company Details
  • 13.2.2 TauRx Business Overview
  • 13.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
  • 13.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.2.5 TauRx Recent Development
• 13.3 Alector
  • 13.3.1 Alector Company Details
  • 13.3.2 Alector Business Overview
  • 13.3.3 Alector Alzheimer's Disease Diagnostic Introduction
  • 13.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.3.5 Alector Recent Development
• 13.4 Accera
  • 13.4.1 Accera Company Details
  • 13.4.2 Accera Business Overview
  • 13.4.3 Accera Alzheimer's Disease Diagnostic Introduction
  • 13.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.4.5 Accera Recent Development
• 13.5 Treventis
  • 13.5.1 Treventis Company Details
  • 13.5.2 Treventis Business Overview
  • 13.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
  • 13.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.5.5 Treventis Recent Development
• 13.6 Neuro-Bio
  • 13.6.1 Neuro-Bio Company Details
  • 13.6.2 Neuro-Bio Business Overview
  • 13.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
  • 13.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.6.5 Neuro-Bio Recent Development
• 13.7 Cognition Therapeutics
  • 13.7.1 Cognition Therapeutics Company Details
  • 13.7.2 Cognition Therapeutics Business Overview
  • 13.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
  • 13.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  • 13.7.5 Cognition Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer